FOMAT - Comprehensive Cardiovascular Care

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation2 trials
• Stroke2 trials
• Heart failure1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Cytokinetics1 trial

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  NCT06793371· Phase 2· Cytokinetics· Source

  Contact: Cytokinetics MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Stroke2 recruiting
• Heart failure1 recruiting